Form 8-K · Item 4.01 · Auditor change
CERo Therapeutics Holdings, Inc.: auditor change, Wolf & Company, P.C. to Salberg & Company, P.A.
CERo Therapeutics Holdings, Inc. reported in a Form 8-K filed February 13, 2026, that on February 13, 2026, Salberg & Company, P.A. was engaged. The filing reports no disagreements with the former accountant.
In the filing's words
approved the decision to dismiss Wolf & Company, P.C. (“Wolf”), as the Company’s independent registered public accounting firm, effective as of February 13, 2026.
the Company has not had any disagreement with Wolf on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures
approved the appointment of Salberg & Company, P.A. (“Salberg”) as the Company’s independent registered public accounting firm, effective following the finalization of the terms of an engagement letter therewith and execution thereof of February 11, 2026, with such appointment effective as of February 13, 2026.
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | CERo Therapeutics Holdings, Inc. |
|---|---|
| Ticker | CERO |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | February 13, 2026 |
| What the filing states | engaged |
| Former accountant | Wolf & Company, P.C. |
| New accountant | Salberg & Company, P.A. |
| Date of the change | February 13, 2026 |
| Disagreements | none reported |
| Auditor's letter | Exhibit 16 on sec.gov |
| Accession number | 0001213900-26-016474 |
| SEC CIK | 0001870404 |
CERo Therapeutics Holdings, Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed February 13, 2026. The filing's own words are quoted above.
Sources
More: all auditor changes · Something wrong? Send a correction with the primary source.